+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report by Enzyme Type (Polymerase & Transcriptase, Proteases), Disease Type, Technology Type, End-use, Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 199 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5921037
Description Jump to:
The global in-vitro diagnostics enzymes market size is expected to reach USD 3.70 billion by 2030, expanding at a CAGR of 7.9% from 2023 to 2030. Accurate and rapid diagnosis and treatment of clinical disorders are essential for optimal clinical outcomes. Owing to the noteworthy biocatalytic properties, enzymes are used in the diagnosis of a wide range of diseases.

The development of enzyme biosensors has increased the enzyme utility in clinical diagnostics. Despite the necessity in clinical diagnosis, the commercialization and translation of biosensors from research to clinics are still low. However, with an increase in R&D efforts, lactate, cholesterol, and glucose biosensors have been commercialized for diagnostic use.

Proteases are important signaling proteins that are critical to a few pathological processes, including cancer, neurological, inflammatory, and cardiovascular disorders. Polymerase and transcriptase enzymes are expected to exhibit the fastest CAGR over the forecast period. In addition, the presence of a substantial number of players that offer these enzymes is expected to enhance the growth. Key players such as Kaneka Eurogentec S.A.; Toyobo Co., Ltd.; and Sekisui Diagnostics, LLC manufacture and distribute a wide range of polymerases, including KOD DNA Polymerase, Taq DNA Polymerase, Tth DNA Polymerase, and TTx DNA Polymerase.

The infectious disease segment dominated the market in 2019. An exponential rise in the COVID-19 cases globally drives the adoption rate of diagnostic enzymes for COVID-19 diagnosis. An increase in the availability of qualitative and quantitative molecular assays based on real-time PCR, Loop-mediated Isothermal Amplification- PCR (LAMP-PCR), multiplex PCR, and digital PCR technologies for the diagnosis of infectious diseases drives the demand for enzymes in this segment.

Enzymatic immunohistochemistry (IHC) is preferred for histology owing to a better contrast ratio and the method’s compatibility for use with multiple stains for the detection of target components. IVD enzymes are employed in different end-use settings for the analysis of tissue specimens and bodily fluids. A wide range of end users including large laboratories that conduct multiple analyses in a day and smaller clinics that conduct a few tests use enzymes for in-vitro diagnostics (IVD).

North America emerged as a prominent regional market in 2019. A rise in the number of cancer cases and the adoption of enzymes for histopathology of biopsy samples are some of the other factors expected to propel market growth in the region. The presence of a large target population, improvements in healthcare infrastructure, high unmet clinical needs, increase in government initiatives, and rise in R&D activities for advanced diagnostic techniques are anticipated to drive the Asia-Pacific market with the fastest growth rate.

The key players in the market are involved in novel product launches, acquisitions, collaborations, partnerships, and geographical expansions to reinforce their market presence. For instance, in June 2020, Codexis, Inc. signed a collaboration agreement with Alphazyme LLC for the manufacture and co-marketing of high-fidelity DNA polymerase, T7 RNA polymerase, and reverse transcriptase.

In-vitro Diagnostics Enzymes Market Report Highlights

  • By enzyme type, polymerase and transcriptase enzymes held the largest share in 2022 owing to their wide applications in molecular diagnostic assays
  • Based on disease type, the infectious disease segment is expected to dominate the market throughout the forecast period
  • In terms of technology type, the histology assays segment held the largest share in 2022 owing to the utility of histology assays in cancer diagnostics, coupled with a rising incidence of different cancer types
  • By end use, hospital and diagnostic labs dominated the market in 2022. They witness a high inflow of biopsy specimens for histopathology and cytopathology because of an increase in hospitalization and rise in the number of hospital admissions for cancer patients
  • North America dominated the overall market in 2022 owing to the presence of a substantial number of players in this region including Innovative Research; Bio-Rad Laboratories, Inc.; Rockland Immunochemicals, Inc.; MyBioSource.com; and RayBiotech, Inc.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Enzyme Type
1.1.2. Disease Type
1.1.3. Technology Type
1.1.4. End use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Enzyme type outlook
2.2.2. Disease type outlook
2.2.3. Technology type outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis
4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Proteases
4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Polymerase & Transcriptase
4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Ribonuclease
4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis
5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious Disease
5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.1. COVID -19 Testing
5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.2. Hepatitis
5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.3. HIV
5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.4. Others
5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Diabetes
5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Oncology
5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiology
5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Nephrology
5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Autoimmune Diseases
5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis
6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Histology Assays
6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Molecular Diagnostics
6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.1. PCR Assays
6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.2. NGS Assays
6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.1.3. Others
6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Clinical Chemistry
6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis
7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Pharma & Biotech
7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Hospital & Diagnostic Labs
7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Academic Labs
7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4. Europe
8.4.1. U.K.
8.4.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5. Asia-Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Merck KGaA
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Codexis, Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. F. Hoffmann-La Roche Ltd.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Amano Enzymes Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Advanced Enzymes Technologies Ltd.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Biocatalysts Ltd.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Amicogen
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Dyadic International
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. BBI Solutions
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Affymetrix
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. American Laboratories
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 3 North America in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 4 North America in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 5 North America in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 6 North America in-vitro diagnostics enzymes market, by region, 2018-2030 (USD Million)
Table 7 U.S. in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 8 U.S. in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 9 U.S. in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 10 U.S. in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 11 Canada in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 12 Canada in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 13 Canada in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 14 Canada in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 15 Europe in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 16 Europe in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 17 Europe in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 18 Europe in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 19 Europe in-vitro diagnostics enzymes market, by region, 2018-2030 (USD Million)
Table 20 Germany in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 21 Germany in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 22 Germany in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 23 Germany in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 24 UK in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 25 UK in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 26 UK in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 27 UK in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 28 France in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 29 France in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 30 France in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 31 France in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 32 Italy in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 33 Italy in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 34 Italy in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 35 Italy in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 36 Spain in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 37 Spain in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 38 Spain in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 39 Spain in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 40 Sweden in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 41 Sweden in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 42 Sweden in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 43 Sweden in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 44 Norway in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 45 Norway in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 46 Norway in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 47 Norway in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 48 Denmark in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 49 Denmark in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 50 Denmark in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 51 Denmark in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 52 Asia-Pacific in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 53 Asia-Pacific in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 54 Asia-Pacific in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 55 Asia-Pacific in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 56 Asia-Pacific in-vitro diagnostics enzymes market, by region, 2018-2030 (USD Million)
Table 57 China in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 58 China in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 59 China in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 60 China in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 61 Japan in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 62 Japan in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 63 Japan in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 64 Japan in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 65 India in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 66 India in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 67 India in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 68 India in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 69 Australia in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 70 Australia in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 71 Australia in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 72 Australia in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 73 Thailand in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 74 Thailand in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 75 Thailand in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 76 Thailand in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 77 South Korea in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 78 South Korea in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 79 South Korea in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 80 South Korea in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 81 Latin America in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 82 Latin America in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 83 Latin America in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 84 Latin America in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 85 Latin America in-vitro diagnostics enzymes market, by region, 2018-2030 (USD Million)
Table 86 Brazil in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 87 Brazil in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 88 Brazil in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 89 Brazil in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 90 Mexico in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 91 Mexico in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 92 Mexico in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 93 Mexico in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 94 Argentina in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 95 Argentina in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 96 Argentina in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 97 Argentina in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 98 Middle East and Africa in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 99 Middle East and Africa in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 100 Middle East and Africa in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 101 Middle East and Africa in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 102 Middle East and Africa in-vitro diagnostics enzymes market, by region, 2018-2030 (USD Million)
Table 103 South Africa in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 104 South Africa in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 105 South Africa in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 106 South Africa in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 107 Saudi Arabia in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 108 Saudi Arabia in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 109 Saudi Arabia in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 110 Saudi Arabia in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 111 UAE in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 112 UAE in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 113 UAE in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 114 UAE in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
Table 115 Kuwait in-vitro diagnostics enzymes market, by enzymes type, 2018-2030 (USD Million)
Table 116 Kuwait in-vitro diagnostics enzymes market, by disease type, 2018-2030 (USD Million)
Table 117 Kuwait in-vitro diagnostics enzymes market, by technology type, 2018-2030 (USD Million)
Table 118 Kuwait in-vitro diagnostics enzymes market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 In-vitro diagnostics enzymes: Market outlook
Figure 9 In-vitro diagnostics enzymes: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 In-vitro diagnostics enzymes market driver impact
Figure 15 In-vitro diagnostics enzymes market restraint impact
Figure 16 In-vitro diagnostics enzymes market strategic initiatives analysis
Figure 17 In-vitro diagnostics enzymes market: Enzyme type movement analysis
Figure 18 In-vitro diagnostics enzymes market: Enzyme type outlook and key takeaways
Figure 19 Proteases market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Polymerase & transcriptase market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Ribonuclease market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 In-vitro diagnostics enzymes market: Disease type movement analysis
Figure 24 In-vitro diagnostics enzymes market: Disease type outlook and key takeaways
Figure 25 Infectious disease market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Diabetes market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Cardiology market estimates and forecasts, 2018-2030
Figure 29 Nephrology market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Autoimmune diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 In-vitro diagnostics enzymes market: Technology type movement analysis
Figure 33 In-vitro diagnostics enzymes market: Technology type outlook and key takeaways
Figure 34 Histology assays market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Clinical chemistry market estimates and forecasts, 2018-2030
Figure 37 Others market estimates and forecasts, 2018-2030
Figure 38 In-vitro diagnostics enzymes market: End use type movement analysis
Figure 39 In-vitro diagnostics enzymes market: End use type outlook and key takeaways
Figure 40 Pharma & biotech market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Hospital & diagnostic labs market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Contract Research Organizations (CROs) market estimates and forecasts, 2018-2030
Figure 43 Academic labs market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Global in-vitro diagnostics enzymes market: Regional movement analysis
Figure 45 Global in-vitro diagnostics enzymes market: Regional outlook and key takeaways
Figure 46 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 U.K. market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Asia-Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Figure 70 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Merck KGaA
  • Codexis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Amano Enzymes Inc.
  • Advanced Enzymes Technologies Ltd.
  • Biocatalysts Ltd.
  • Amicogen
  • Dyadic International
  • BBI Solutions
  • Affymetrix
  • American Laboratories

Methodology

Loading
LOADING...

Related Topics

Related Reports

Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Plants, Animal, Microorganisms), By Product (Carbohydrase, Proteases, Polymerases & Nucleases), By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Plants, Animal, Microorganisms), By Product (Carbohydrase, Proteases, Polymerases & Nucleases), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Specialty Enzymes Market by Type (Carbohydrases, Lipases, Polymerases & Nucleases), Source (Animal, Microorganisms, Plants), Form, Application - Forecast 2024-2030 - Product Image

Global Specialty Enzymes Market by Type (Carbohydrases, Lipases, Polymerases & Nucleases), Source (Animal, Microorganisms, Plants), Form, Application - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Diagnostic Enzyme Global Market Report 2024 - Product Image

Diagnostic Enzyme Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Enzymes Market Size, Share & Trends Analysis Report By Product (Carbohydrase, Proteases, Polymerases & Nucleases), By Type (Industrial, Specialty), By Source (Plants, Animals), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Enzymes Market Size, Share & Trends Analysis Report By Product (Carbohydrase, Proteases, Polymerases & Nucleases), By Type (Industrial, Specialty), By Source (Plants, Animals), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 140 Pages
  • Global
From
Global Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Forecast 2024-2030 - Product Image

Global Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.